| 1. |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2018, 68(6): 394-424.
|
| 2. |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin, 2016, 66(2): 115-132.
|
| 3. |
Yang P, Zhou Y, Chen B, et al. Overweight, obesity and gastric cancer risk: results from a meta-analysis of cohort studies. Eur J Cancer, 2009, 45(16): 2867-2873.
|
| 4. |
Cho DH, Kim MN, Joo HJ, et al. Visceral obesity, but not central obesity, is associated with cardiac remodeling in subjects with suspected metabolic syndrome. Nutr Metab Cardiovasc Dis, 2019, 29(4): 360-366.
|
| 5. |
黄婷婷, 张向君, 周玉荣, 等. ob/ob 鼠肠系膜脂肪、肝脏、骨骼肌 miR-143 表达变化及其临床意义. 西北国防医学杂志, 2013, 34(5): 413-414.
|
| 6. |
Yamaji T, Iwasaki M, Sawada N, et al. Fat mass and obesity-associated gene polymorphisms, pre-diagnostic plasma adipokine levels and the risk of colorectal cancer: The Japan Public Health Center-based Prospective Study. PLoS One, 2020, 15(2): e0229005.
|
| 7. |
肖繁, 郭笑宇, 王刚, 等. 消化系统微生态与胰腺癌的研究现状和发展. 中华消化外科杂志, 2019, 18(10): 1001-1004.
|
| 8. |
Schoemaker MJ, Nichols HB, Wright LB, et al. Adult weight change and premenopausal breast cancer risk: A prospective pooled analysis of data from 628,463 women. Int J Cancer, 2020, 147(5): 1306-1314.
|
| 9. |
Tan Y, Zhang X, Zhang W, et al. The influence of metabolic syndrome on the risk of hepatocellular carcinoma in patients with chronic hepatitis B infection in Mainland China. Cancer Epidemiol Biomarkers Prev, 2019, 28(12): 2038-2046.
|
| 10. |
Carr JS, Zafar SF, Saba N, et al. Risk factors for rising incidence of esophageal and gastric cardia adenocarcinoma. J Gastrointest Cancer, 2013, 44(2): 143-151.
|
| 11. |
Miyazaki R, Hoka S, Yamaura K. Visceral fat, but not subcutaneous fat, is associated with lower core temperature during laparoscopic surgery. PLoS One, 2019, 14(6): e0218281.
|
| 12. |
Kang J, Baek SE, Kim T, et al. Impact of fat obesity on laparoscopic total mesorectal excision: more reliable indicator than body mass index. Int J Colorectal Dis, 2012, 27(4): 497-505.
|
| 13. |
Tchernof A, Després JP. Pathophysiology of human visceral obesity: an update. Physiol Rev, 2013, 93(1): 359-404.
|
| 14. |
Silveira EA, Kliemann N, Noll M, et al. Visceral obesity and incident cancer and cardiovascular disease: An integrative review of the epidemiological evidence. Obes Rev, 2021, 22(1): e13088.
|
| 15. |
Qi J, Hu H, Yaghjyan L, et al. Association of adipose tissue distribution with type 2 diabetes in breast cancer patients. Breast Cancer (Auckl), 2020, 14: 1178223420972369.
|
| 16. |
Lee DH, Park KS, Ahn S, et al. Comparison of abdominal visceral adipose tissue area measured by computed tomography with that estimated by bioelectrical impedance analysis method in Korean subjects. Nutrients, 2015, 7(12): 10513-10524.
|
| 17. |
Gao B, Liu Y, Ding C, et al. Comparison of visceral fat area measured by CT and bioelectrical impedance analysis in Chinese patients with gastric cancer: a cross-sectional study. BMJ Open, 2020, 10(7): e036335.
|
| 18. |
Eto K, Ida S, Ohashi T, et al. Perirenal fat thickness as a predictor of postoperative complications after laparoscopic distal gastrectomy for gastric cancer. BJS Open, 2020, 4(5): 865-872.
|
| 19. |
Amato MC, Giordano C, Galia M, et al. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care, 2010, 33(4): 920-922.
|
| 20. |
Okamura T, Hashimoto Y, Hamaguchi M, et al. Visceral Adiposity Index is a predictor of incident colorectal cancer: a population-based longitudinal study. BMJ Open Gastroenterol, 2020, 7(1): e000400.
|
| 21. |
Steffen A, Huerta JM, Weiderpass E, et al. General and abdominal obesity and risk of esophageal and gastric adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer, 2015, 137(3): 646-657.
|
| 22. |
Li HJ, Fu JK, Che XM, et al. Obesity accelerates murine gastric cancer growth by modulating the Sirt1/YAP pathway. Oncol Lett, 2017, 14(4): 4151-4157.
|
| 23. |
Chen X, Chen W, Huang Y, et al. A quantified risk-scoring system including the visceral fat area for peritoneal metastasis of gastric cancer. Cancer Manag Res, 2019, 11: 2903-2913.
|
| 24. |
Huang H, Yang X, Sun J, et al. Value of visceral fat area in the preoperative discrimination of peritoneal metastasis from gastric cancer in patients with different body mass index: A prospective study. Cancer Manag Res, 2020, 12: 6523-6532.
|
| 25. |
Yang SJ, Li HR, Zhang WH, et al. Visceral fat area (VFA) superior to BMI for predicting postoperative complications after radical gastrectomy: a prospective cohort study. J Gastrointest Surg, 2020, 24(6): 1298-1306.
|
| 26. |
付广华, 牛兆建, 周岩冰, 等. 内脏脂肪面积对腹腔镜胃癌根治术的影响. 中华胃肠外科杂志, 2015, 18(8): 804-807.
|
| 27. |
Okubo K, Uenosono Y, Arigami T, et al. Clinical significance of altering epithelial-mesenchymal transition in metastatic lymph nodes of gastric cancer. Gastric Cancer, 2017, 20(5): 802-810.
|
| 28. |
Go JE, Kim MC, Kim KH, et al. Effect of visceral fat area on outcomes of laparoscopyassisted distal gastrectomy for gastric cancer: subgroup analysis by gender and parameters of obesity. Ann Surg Treat Res, 2015, 88(6): 318-324.
|
| 29. |
Del Rio P, Bernuzzi E, Bertocchi E, et al. Relationship between postoperative complications and survival after gastrectomy for cancer. Ann Ital Chir, 2017, 88: S0003469X17027063.
|
| 30. |
Okada K, Nishigori T, Obama K, et al. The incidence of postoperative complications after gastrectomy increases in proportion to the amount of preoperative visceral fat. J Oncol, 2019, 2019: 8404383.
|
| 31. |
Kim JH, Kim J, Lee WJ, et al. A high visceral-to-subcutaneous fat ratio is an independent predictor of surgical site infection after gastrectomy. J Clin Med, 2019, 8(4): 494.
|
| 32. |
Wang SL, Ma LL, Chen XY, et al. Impact of visceral fat on surgical complications and long-term survival of patients with gastric cancer after radical gastrectomy. Eur J Clin Nutr, 2018, 72(3): 436-445.
|
| 33. |
Cho H, Yoshikawa T, Oba MS, et al. Matched pair analysis to examine the effects of a planned preoperative exercise program in early gastric cancer patients with metabolic syndrome to reduce operative risk: the Adjuvant Exercise for General Elective Surgery (AEGES) study group. Ann Surg Oncol, 2014, 21(6): 2044-2050.
|
| 34. |
Inoue K, Yoshiuchi S, Yoshida M, et al. Preoperative weight loss program involving a 20-day very low-calorie diet for obesity before laparoscopic gastrectomy for gastric cancer. Asian J Endosc Surg, 2019, 12(1): 43-50.
|
| 35. |
Feng W, Huang M, Zhao X, et al. Severe loss of visceral fat and skeletal muscle after chemotherapy predicts poor prognosis in metastatic gastric cancer patients without gastrectomy. J Cancer, 2020, 11(11): 3310-3317.
|
| 36. |
Fujiwara N, Nakagawa H, Kudo Y, et al. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol, 2015, 63(1): 131-140.
|
| 37. |
Park HS, Kim HS, Beom SH, et al. Marked loss of muscle, visceral fat, or subcutaneous fat after gastrectomy predicts poor survival in advanced gastric cancer: single-center study from the CLASSIC trial. Ann Surg Oncol, 2018, 25(11): 3222-3230.
|
| 38. |
Kolb R, Sutterwala FS, Zhang W. Obesity and cancer: inflammation bridges the two. Curr Opin Pharmacol, 2016, 29: 77-89.
|
| 39. |
Fernandes JV, Cobucci RN, Jatobá CAN, et al. The role of the mediators of inflammation in cancer development. Pathol Oncol Res, 2015, 21(3): 527-534.
|
| 40. |
Lin Y, He Z, Ye J, et al. Progress in understanding the IL-6/STAT3 pathway in colorectal cancer. Onco Targets Ther, 2020, 13: 13023-13032.
|
| 41. |
Ju X, Zhang H, Zhou Z, et al. Tumor-associated macrophages induce PD-L1 expression in gastric cancer cells through IL-6 and TNF-ɑ signaling. Exp Cell Res, 2020, 396(2): 112315.
|
| 42. |
Li G, Wulan H, Song Z, et al. Regulatory B cell function is suppressed by smoking and obesity in H. pylori-infected subjects and is correlated with elevated risk of gastric cancer. PLoS One, 2015, 10(7): e0134591.
|
| 43. |
Nieman KM, Romero IL, Van Houten B, et al. Adipose tissue and adipocytes support tumorigenesis and metastasis. Biochim Biophys Acta, 2013, 1831(10): 1533-1541.
|
| 44. |
Muppala S, Konduru SKP, Merchant N, et al. Adiponectin: Its role in obesity-associated colon and prostate cancers. Crit Rev Oncol Hematol, 2017, 116: 125-133.
|
| 45. |
Mhaidat NM, Alzoubi KH, Kubas MA, et al. High levels of leptin and non-high molecular weight-adiponectin in patients with colorectal cancer: Association with chemotherapy and common genetic polymorphisms. Biomed Rep, 2021, 14(1): 13.
|
| 46. |
Xie L, Wang Y, Wang S, et al. Adiponectin induces growth inhibition and apoptosis in cervical cancer HeLa cells. Biologia, 2011, 66(4): 712-720.
|
| 47. |
Mauro L, Naimo GD, Gelsomino L, et al. Uncoupling effects of estrogen receptor α on LKB1/AMPK interaction upon adiponectin exposure in breast cancer. FASEB J, 2018, 32(8): 4343-4355.
|
| 48. |
Bi TQ, Che XM. Nampt/PBEF/visfatin and cancer. Cancer Biol Ther, 2010, 10(2): 119-125.
|
| 49. |
Deng T, Lyon CJ, Bergin S, et al. Obesity, inflammation, and cancer. Annu Rev Pathol, 2016, 11: 421-449.
|
| 50. |
Kalantarhormozi M, Jouyan N, Asadipooya K, et al. Evaluation of adipokines, adiponectin, visfatin, and omentin, in uncomplicated type Ⅰ diabetes patients before and after treatment of diabetic ketoacidosis. J Endocrinol Invest, 2020, 43(12): 1723-1727.
|
| 51. |
Cao J, Yee D. Disrupting insulin and IgF receptor function in cancer. Int J Mol Sci, 2021, 22(2): E555.
|
| 52. |
van Bree SH, Cailotto C, Di Giovangiulio M, et al. Systemic inflammation with enhanced brain activation contributes to more severe delay in postoperative ileus. Neurogastroenterol Motil, 2013, 25(8): e540-e549.
|
| 53. |
Iida M, Takeda S, Nakagami Y, et al. The effect of the visceral fat area on the predictive accuracy of C-reactive protein for infectious complications after laparoscopy-assisted gastrectomy. Ann Gastroenterol Surg, 2020, 4(4): 386-395.
|
1/5
WeChat